Palvella Therapeutics (PVLA) Net Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128.29% |
| Dec 31, 2025 | -39.55% |
| Sep 30, 2025 | -18.88% |
| Jun 30, 2025 | -6.18% |
| Mar 31, 2025 | 11.54% |
| Dec 31, 2024 | 34.42% |
| Sep 30, 2024 | 53.13% |
| Jun 30, 2024 | 33.60% |
| Mar 31, 2024 | 19.00% |
| Dec 31, 2023 | 21.42% |
| Sep 30, 2023 | -18.10% |
| Jun 30, 2023 | 15.85% |
| Mar 31, 2023 | -58.22% |
| Dec 31, 2022 | 24.82% |
| Sep 30, 2022 | -15.80% |
| Jun 30, 2022 | -35.54% |
| Mar 31, 2022 | -26.90% |
| Dec 31, 2021 | 1.73% |
| Sep 30, 2021 | 30.93% |
| Jun 30, 2021 | 41.82% |
| Mar 31, 2021 | -26.68% |
| Dec 31, 2020 | 20.42% |
| Sep 30, 2020 | -1.53% |
| Jun 30, 2020 | -3.57% |
| Mar 31, 2020 | -25.32% |
| Sep 30, 2019 | -218.80% |
| Jun 30, 2019 | 25.59% |
| Mar 31, 2019 | -117.48% |
| Dec 31, 2018 | -637.96% |
| Sep 30, 2018 | 513.84% |
| Jun 30, 2018 | -544.20% |